Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in ...
In 2025, the overall U.S. death rate was down 4.6% from 2024, according to a July Vital Statistics Rapid Release report, a ...
Modern IVF treatment can now achieve substantially higher success rates than historical approaches while dramatically ...
A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...
A new study published in JMIR XR and Spatial Computing demonstrates that the way virtual reality therapeutics (VRx) are ...
A molecule linked to chronic inflammation disrupts the brain's ability to create new neurons, uncovering a pathway with ...
Researchers from UC Davis Medical Center have identified significant socioeconomic disparities among patients seeking ...
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED).
One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including ...
Early menopause affects 1 in 14 women ages 30 to 49 living in low- and middle-income countries, according to a pooled data ...
A major new study, published in The Lancet Diabetes & Endocrinology, has shown that cortisol levels in patients with adrenal ...
Two in five women with ovarian cancer are diagnosed only after an emergency hospital admission, when they are three times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results